Brain Tumor Pathology

Papers
(The TQCC of Brain Tumor Pathology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Intraspinal ASPSCR1::TFE3 rearranged tumor with nerve differentiation22
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recu20
Preface for Brain Tumor Pathology vol.41 issue 215
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma14
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis13
Double-hit primary central nervous system lymphoma with histogenetically proven bone marrow infiltration: a case report and a review of the literature13
Targeting TGF-β signaling in glioblastoma: therapeutic implications and novel drug development strategies12
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma12
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment11
Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lym10
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next10
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next9
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation8
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors7
Gyriform infiltration indicates tumor invasion burden of isocitrate dehydrogenase 1/2-wildtype gliomas6
Three-dimensional visualization of human brain tumors using the CUBIC technique6
Biphasic high-grade cerebellar glioma with epithelial-like components: challenges in integrated diagnosis imposed by limited sampling5
Exploratory analysis of miRNAs-21, -26a, -34a, -181c, -181d, and -485-5p as potential biomarkers for tumor treating fields sensitivity in primary glioblastoma cell cultures5
Rare intracranial mesenchymal tumors with FET::CREB fusions: clinicopathologic spectrum of four cases with integrated molecular analysis and review of the literature5
Comparative molecular profiles of distinct tumor components in recurrent tentorial meningioma after stereotactic radiosurgery: a case report implicating acquired aggressive alterations associated with4
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment4
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis4
Integrated analysis of MYC expression, 8q24.21 copy number, and recurrence patterns in astrocytoma, IDH-mutant4
Integrated analysis of multiple methods reveals characteristics of the immune microenvironment in medulloblastoma4
Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas4
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas4
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report4
Triple sellar collision lesion: a unique case of pituitary adenoma, Rathke cleft cyst, and xanthogranuloma—case report and systematic review of the literature4
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis4
Utility of digital PCR for detecting TERT promoter mutations and CDKN2A homozygous deletion in meningioma4
Revisiting the definition of glioma recurrence based on a phylogenetic investigation of primary and re-emerging tumor samples: a case report4
Meningioma with trabecular architecture: a harbinger of BAP1 deficiency4
Diverse NF2 alterations in cranial schwannomas: a two-case series of germline whole-gene deletion and somatic in-frame deletion4
0.027167081832886